Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 2003; 12(3):179- 82.Zullo A,,Romiti A,Tomao S,et al.Gastric cancer preva-lence in patients with liver cirrhosis. European Journal of Cancer Prevention . 2003...
The National Cancer Screening Program (NCSP) has implemented esophagogastroduodenoscopy (EGD) biennially for all Koreans starting in their 40s. This study was conducted to estimate the clinical relevance of NCSP through identifying the prevalence of gastric disease, including cancer. Materials and ...
https://seer.cancer.gov/qi/process.html 28. Engholm G, Ferlay J, Christensen N, et al. Cancer incidence, mortality, prevalence and survival in the Nordic countries. Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society; 2018. Accessed March ...
There was a significant 2.6-fold (P<0.01) increase in prevalence of gastric cancer compared with that expected in our cirrhotic patients. In conclusion, our findings confirm that liver cirrhosis would seem to be a risk factor for the development of gastric cancer. Other studies are needed to ...
The prevalence of premalignant gastric lesions is considerable in general Western population with increasing age as the main risk factor. One time screening for premalignant lesions at the age of 60 years is a reasonable strategy since the numbers found imply that gastric cancer will remain a preval...
We compared the prevalence rates of peptic ulcer (duodenal and gastric) and gastric cancer in 1,796 dyspeptic Peruvian patients with those reported in 2,883 similar patients from developed countries. The prevalence of total peptic ulcer was significantly lower, and that of gastric cancer significant...
Gastric cancer is the fifth most common malignancy and fourth leading cause of cancer death worldwide.1-2Although gastric cancer rates have declined in the United States over the past decade, prevalence rates are rising in other parts of the world, especially East Asia. It is...
The burdens and trends of gastric cancer are poorly understood, especially in high-prevalence countries. Based on the Global Burden of Disease Study 2019, we analyzed the incidence, death, and possible risk factors of gastric cancer in five Asian countries, in relation to year, age, sex, and...
Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate years lived with disability (YLDs). In this study, we searched the GBD 2019 database and collected data on gastric cancer incidence, prevalence, mortality, YLLs, YLDs, and...
CA72-4 Gastric cancer Biomarker Predictor Targeted therapy 1. Introduction Gastric cancer (GC) is a highly aggressive and fatal malignancy. It is the fifth most common tumor and the third deadliest cancer worldwide [1]. Nearly 1 million new cases of GC are reported each year, and about half...